Multigene panel testing versus syndrome-specific germline testing for inherited cancer risk: 'a somewhat different way'

Per Med. 2019 Mar;16(2):83-86. doi: 10.2217/pme-2018-0109. Epub 2019 Feb 11.

Authors

Leah H Biller¹, Matthew B Yurgelun²

Affiliations

¹ Beth Israel Deaconess Medical Center, Department of Medicine, Division of Hematology and Oncology, Boston, MA 02215, USA.
² Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA 02215, USA.

PMID: 30741585
DOI: 10.2217/pme-2018-0109

No abstract available

Keywords: Lynch syndrome; cancer genetics; familial cancers; hereditary breast and ovarian cancer; multiplex testing.

Publication types

Editorial

MeSH terms

Colorectal Neoplasms, Hereditary Nonpolyposis / diagnosis
Genetic Predisposition to Disease / genetics
Genetic Testing / methods*
Genetic Testing / trends*
Germ Cells
Humans
Neoplasms / genetics
Risk Factors
Syndrome